marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-05-2024
AnaptysBio Financial Ratios 2011-2024 | ANAB
Annual Financial Ratios AnaptysBio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.8 | -5.4 | -16.5 | -29.5 | -4.0 | -26.1 | -70.2 | -73.2 | - | - | - | - | - |
P/S |
36.6 | 68.0 | 15.1 | 7.8 | 49.2 | 322.4 | 211.1 | 18.7 | - | - | - | - | - |
EPS |
-6.1 | -4.6 | -2.1 | -0.7 | -3.6 | -2.5 | -1.5 | -1.6 | -2.1 | - | - | - | - |
EV (Enterprise Value) |
593 M | 629 M | 457 M | 336 M | 253 M | 1.52 B | 2.05 B | 283 M | -37.8 M | 19.1 M | 3.77 M | - | - |
EBITDA per Share |
-6.08 | -4.06 | -2.05 | -0.85 | -3.95 | -2.69 | -1.45 | -0.154 | - | - | - | - | - |
EV/EBITDA |
-7.8 | -19.7 | -2.1 | -22.7 | -71.5 | -98.2 | - | - | - | - | - | ||
PEG |
-0.07 | -0.09 | -0.08 | -0.45 | 0.09 | 0.41 | 0.13 | -1.4 | - | - | - | - | - |
P/B |
1.4 | 1.1 | 1.5 | 1.4 | 1.0 | 3.3 | 6.9 | 7.9 | - | - | - | - | - |
P/CF |
-5.2 | -9.5 | -20.8 | -41.5 | -5.6 | -32.5 | -107.0 | -34.3 | - | - | - | - | - |
ROE % |
-185.71 | -49.11 | -16.22 | -5.02 | -24.03 | -12.68 | -9.78 | -10.85 | - | - | - | - | - |
ROA % |
-36.17 | -21.09 | -8.99 | -4.78 | -22.37 | -12.11 | -9.13 | -6.85 | - | - | - | - | - |
ROCE % |
-186.61 | -43.93 | -15.94 | -6.02 | -26.48 | -13.70 | -9.13 | -5.36 | - | - | - | - | - |
Current Ratio |
- | - | - | - | 12.8 | 19.9 | 17.9 | 10.2 | - | - | - | - | - |
DSO |
88.0 | 40.7 | 2.5 | - | - | 12.7 | 58.4 | 116.9 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
88.0 | 40.7 | 2.5 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
88.0 | 40.7 | 2.5 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios AnaptysBio
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.14 | -1.71 | -1.64 | - | -1.41 | -1.5 | -1.58 | - | -1.18 | -1.15 | -1.31 | - | -0.24 | -0.02 | -0.66 | - | -0.87 | -0.79 | -0.3 | -0.75 | -1.15 | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 | -0.63 | -0.3 | -0.45 | -0.13 | -0.75 | -1.73 | -0.42 | 0.07 | -0.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.57 | - | - | - | -1.58 | - | -1.03 | -0.97 | -1.14 | - | -0.23 | -0.01 | -0.67 | - | -0.88 | -0.82 | -0.37 | -0.82 | -1.23 | -0.98 | -0.91 | -0.73 | -0.69 | -0.6 | -0.66 | -0.3 | -0.44 | -0.12 | -0.65 | -1.2 | -0.34 | 0.94 | -0.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-634.20 | -626.26 | -180.78 | -80.99 | -93.06 | -74.13 | -57.99 | -33.73 | -35.46 | -25.13 | -14.55 | -6.60 | -12.60 | -16.85 | -22.17 | -13.50 | -18.51 | -20.18 | -20.66 | -24.03 | -22.52 | -18.14 | -15.03 | -12.68 | -11.41 | -11.09 | -9.16 | -9.78 | 4.42 | 10.29 | 5.10 | 11.14 | -0.83 | -3.75 | 2.32 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-36.06 | -37.06 | -33.84 | -23.38 | -28.80 | -26.56 | -24.24 | -16.61 | -18.18 | -14.33 | -9.04 | -6.25 | -11.96 | -16.09 | -21.17 | -12.86 | -17.52 | -18.94 | -19.28 | -22.37 | -21.05 | -17.05 | -14.22 | -12.11 | -10.86 | -10.48 | -8.62 | -9.13 | -14.41 | -13.44 | -8.89 | -6.85 | 0.51 | 2.31 | -1.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-554.79 | -559.16 | -178.06 | -81.62 | -92.29 | -71.62 | -53.72 | -29.41 | -31.17 | -22.26 | -13.26 | -6.71 | -12.84 | -17.21 | -22.78 | -14.42 | -19.92 | -22.12 | -22.99 | -26.53 | -25.07 | -20.21 | -16.60 | -13.72 | -12.00 | -11.48 | -9.35 | -9.36 | 1.27 | 7.03 | 1.68 | 7.91 | -0.39 | -3.20 | 2.98 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
32.2 | 66.9 | 88.6 | - | 88.7 | 62.0 | 97.7 | - | 78.1 | 73.3 | 84.5 | - | 3.1 | 2.9 | 5.1 | - | - | - | - | - | - | 45.6 | - | - | 45.6 | - | - | - | - | - | - | - | 34.8 | 19.1 | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
32.2 | 66.9 | 88.6 | - | 88.7 | 62.0 | 97.7 | - | 78.1 | 73.3 | 84.5 | - | 3.1 | 2.9 | 5.1 | - | - | - | - | - | - | 45.6 | - | - | 45.6 | - | - | - | - | - | - | - | 34.8 | 19.1 | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
32.2 | 66.9 | 88.6 | - | 88.7 | 62.0 | 97.7 | - | 78.1 | 73.3 | 84.5 | - | 3.1 | 2.9 | 5.1 | - | - | - | - | - | - | 45.6 | - | - | 45.6 | - | - | - | - | - | - | - | 34.8 | 19.1 | 11.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency